Thursday, May 16, 2019

Protocol (Field Tail and Intervention Studies) Assignment

Protocol (Field Tail and Intervention Studies) - Assignment ExampleThe disease is widespread and usually fatal. It mainly targets the human lungs. The disease can however separate body parts. The main elbow room of spreading the disease is through the air as tuberculosis patients sneeze, cough, or transmit their respiratory fluids to other people through the air. TB has been found to be a result of immortality. In the year 2009, it caused faithful to 1.68 million deaths globally.(1) It has been estimated that the world prevalence of latent mycobacterium tuberculosis infections stands at about 32 per cent. TB is also considered dangerous in the sense that it remains the second leading cause of death from a single infectious agent, specifically after HIV/AIDS. According to Martineau (2012), latent Mycobacterium tuberculosis carries a 5 to 20 per cent lifetime reactivation disease risk.(2) In other words, one in both three people around the world has latent TB. In this case, the in fection is contained by the immune arranging such that, those individuals having the latent TB do not develop or spread the disease.3 About 10 per cent will progress from latent to active TB but the risk is greater among those with sealed risk factors, such as HIV/AIDS and tobacco usage. Those who develop active TB may only portray mild symptoms for several months. During this time, such patients can infect between 10 and 15 people every year.(4)Drug-resistant organisms emergence triggered the development of new and better agents for enhancing antimicrobial response as with repute to active TB therapy.(5) Vitamin D was used for the treatment of TB during the pre-antibiotic era. Studies have gone to an extent of identifying a certain protein that seems to play a major role in the protection of people infected with the Mycobacterium tuberculosis. Mycobacterium tuberculosis is the bacteria, which causes TB, including the development of the active form of TB. Interleukin-32 is said to have

No comments:

Post a Comment